Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease

被引:11
作者
Gao, Lu [1 ]
Zhao, Wei [1 ]
Yang, Jin-Kui [2 ]
Qin, Ming-Zhao [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Geriatr, Beijing 100730, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
关键词
HEART-DISEASE; RISK-FACTORS; CHINESE; MORTALITY; EVENTS; COMPLICATIONS; PREVALENCE; RESTENOSIS; SEVERITY; SYSTEM;
D O I
10.1186/s13098-021-00666-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Atherosclerosis cardiovascular disease (ASCVD) is the main cause of morbidity and mortality in type 2 diabetes mellitus (T2DM). As most diabetic patients with ASCVD are asymptomatic, it is most neglected in clinical practice. For this reason, identifying high-risk ASCVD population with intensified treatment is very important. In recent years, the relationship between diabetic retinopathy (DR) and ASCVD has caused much academic concern, but the results are inconsistent. Moreover, whether all grades of DR increase the risk of ASCVD remains controversial. Most importantly, very few data can be found in China. Objective Our aim is to discuss whether all grades of DR increase the risk of ASCVD after adjustment for the traditional cardiovascular risk factors and to assess the independent contribution of DR to cardiovascular events in patients with T2DM, hoping to provide more evidence for early identification of ASCVD. Research design and methods A total of 425 T2DM patients with complete physical and biochemical data were included in the study. The grade of DR was assessed with two 45 color digital retinal images. Based on the presence of history of ASCVD, 425 T2DM patients were divided into 2 groups: ASCVD group and non-ASCVD group. Results ASCVD patients were older and had a significantly higher fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) and proportion of history of ASCVD. At the same time, they were more likely to be females, and had lower level of alcohol and calculated glomerular filtration rate (eGFR) than non-ASCVD patients. Their trend to develop DR with ASCVD was significantly higher than patients with non-ASCVD (chi(2) = 5.805, P = 0.016). DR was an independent statistical indicator of the presence of ASCVD [odds ratio (OR) (95% CI): 2.321 (1.152-4.678), P = 0.018]. Furthermore, when DR was divided into non-proliferative retinopathy (NPDR) and proliferative retinopathy (PDR) according to its severity, only PDR was significantly associated with incident ASCVD [OR (95% CI): 8.333 (1.813-38.304), P = 0.006]. After adjusting for traditional ASCVD risk factors, such an association still existed [OR (95% CI): 7.466 (1.355-41.137), P = 0.021]. Conclusion DR associates strongly with ASCVD in the Chinese population with T2DM. With the increasing severity of DR, the risk of ASCVD also increases. After adjustment for traditional risk factors, PDR is still an independent risk marker for ASCVD.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus
    Miyamoto, Michiaki
    Kotani, Kazuhiko
    Okada, Kenta
    Fujii, Yasutomo
    Konno, Kei
    Ishibashi, Shun
    Taniguchi, Nobuyuki
    ACTA DIABETOLOGICA, 2012, 49 (01) : 63 - 68
  • [42] Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes
    Mitchell, Sabrina L.
    Neininger, Abigail C.
    Bruce, Carleigh N.
    Chocron, Isaac M.
    Bregman, Jana A.
    Estopinal, Christopher B.
    Muhammad, Ayesha
    Umfress, Allison C.
    Jarrell, Kelli L.
    Warden, Cassandra
    Harlow, Paula A.
    Wellons, Melissa
    Samuels, David C.
    Brantley, Milam A., Jr.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (14) : 6481 - 6488
  • [43] Use of Anthropometric Measures of Obesity to Predict Diabetic Retinopathy in Patients with Type 2 Diabetes in China
    Yi, Qiu-Xue
    Zhu, Li-Na
    Ma, Jing
    Yu, Xin-Jie
    Liu, Lin
    Shen, Jie
    DIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 4089 - 4095
  • [44] Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients
    Anan, Futoshi
    Takayuki, Masaki
    Takahashi, Naohiko
    Nakagawa, Mikiko
    Eshima, Nobuoki
    Saikawa, Tetsunori
    Yoshimatsu, Hironobu
    HYPERTENSION RESEARCH, 2009, 32 (04) : 299 - 305
  • [45] Predictive value of the SYNTAX score for diabetic retinopathy in stable coronary artery disease patients with a concomitant type 2 diabetes mellitus
    Kurtul, Bengi Ece
    Kurtul, Alparslan
    Yalcin, Fatih
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [46] Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes
    Lu, Jun
    Hou, Xuhong
    Zhang, Lei
    Jiang, Fusong
    Hu, Cheng
    Bao, Yuqian
    Jia, Weiping
    ACTA DIABETOLOGICA, 2015, 52 (04) : 701 - 708
  • [47] Factors Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus
    He, Bin-Bin
    Wei, Li
    Gu, Yun-Juan
    Han, Jun-Feng
    Li, Ming
    Liu, Yu-Xiang
    Bao, Yu-Qian
    Jia, Wei-Ping
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [48] Relationship Between Muscle Cramps and Diabetic Retinopathy in Patients with Type 2 Diabetes
    Hu, Huiqing
    Wang, Chuan
    Liang, Kai
    He, Qin
    Song, Jia
    Guo, Xinghong
    Hou, Xinguo
    Chen, Li
    Yan, Fei
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 827 - 837
  • [49] Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy
    Magri, Caroline Jane
    Calleja, Neville
    Buhagiar, Gerald
    Fava, Stephen
    Vassallo, Josanne
    POSTGRADUATE MEDICAL JOURNAL, 2011, 87 (1032) : 658 - 663
  • [50] Proliferative diabetic retinopathy as the initial presenting feature of type 1 diabetes
    Ranathunga, Ishara
    Idampitiya, Chandima
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2023, 2023 (04)